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The active site sequence of a fl-lactamase ncoded by chromosomal gene(s) in Citrobacter f eundii GN346 
was determined usihg dansyl-penicillin as a fluorescent probe. The tryptic digest of the labelled enzyme gave 
a fluorescent peptide containing 22 amino acids. The sequence of this peptide was identical to the consensus 
sequence of class C fl-lactamases, Gly-Ser-X-Ser-Lys. The residue labelled was the serine adjacent to the 
glycine. The active site sequence corresponded to positions 464i7 of the entire sequence of the Citrobacter 
freundii fl-lactamase determined on the basis of the DNA sequence of the structural gene [(1986) Eur. J. 
Biochem. 156, 441-445]. The labelled serine corresponded to Ser-64. 
Active site; Dansyl-penicillin; flLactamase; Amino acid sequence; (C. freundii) 
1. INTRODUCTION 
Most chromosomal ~'-lactamases in gram- 
negative bacteria are cephalosporinase-type en-
zymes [2-4]. The clinical importance of these 
cephalosporinases is increasing because cephalo- 
sporinase-producing bacteria are generally resis- 
tant to both cephalosporins and penicillins [5]. 
The Citrobacter freundii cephalosporinase is a 
typical cephalosporinase with respect o substrate 
specificity and physical properties [2]. We have 
studied the mechanism of cephalosporinase inac- 
tivation by novel mechanism-based inactivators 
[6-8] using the C. freundii GN346 enzyme as a 
model enzyme. In order to clarify the interaction 
between the inactivators and the enzyme at the 
molecular level, it is necessary to know the amino 
acid sequence around the active site of the enzyme. 
Recently, the entire base sequence of the C. freun- 
dii cephalosporinase g ne was reported by Lind- 
berg and Normark [1]. Although the active site was 
identified on the basis of the known active sites of 
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cephalosporinases [9,10], the active site sequence 
should be directly determined after isolation of the 
active site peptide. 
We tried to determine the active site sequence of 
the C. freundii cephalosporinase using dansyl- 
penicillin as a fluorescent probe for detection of 
the active site. Although dansyl-penicillin has 
previously been employed only for a penicillinase- 
type enzyme [11], our study revealed that the 
fluorescent method is also applicable to cephalo- 
sporinase-type enzymes, and that it is a convenient 
technique. 
In this paper, we report he determination of the 
22-amino acid sequence around the active site of 
the cephalosporainse produced by C. freundii 
GN346. 
2. MATERIALS AND METHODS 
2.1. Enzyme and chemicals 
/5'-Lactamase from C. freundii GN346 was 
purified by the procedure described in [6]. Dansyl- 
penicillin was synthesized from 6-aminopenicil- 
lanic acid and dansyl chloride according to Cart- 
wright and Fink [11]. Tosylphenylalanylchloro- 
methane (TPCK)-treated trypsin and thermolysin 
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were purchased from Sigma (St. Louis, MO, 
USA). 
2.2. Fractionation of peptides 
HPLC of peptides digested with trypsin or ther- 
molysin was carried out with a Spectra Physics 
model 8700 apparatus on a column (25 cm x 0.46 
cm in diameter) filled with Bakerbond wide-pore 
butyl (C4) (5/~m) (J.T. Baker, Phillipsburg, NH, 
USA) unless otherwise stated. Elution was per- 
formed with a linear gradient of 5-50°70 aceto- 
nitrile containing 0.1070 trifluoroacetic acid for 30 
min at a flow rate of 1.5 ml/min, and 1 min frac- 
tions were collected. 
2.3. Polyacrylamide gel electrophoresis, amino 
acid composition analysis and sequencing 
of labelled peptides 
Electrophoresis at pH 11.7 of the peptides, 
which had been labelled with 8-isothiocyanate- 
1,3,6-trisulfonylpyrene (TSPITC), was carried out 
according to Tsugita et al. [12]. The amino acid 
composition was determined with a Hitachi model 
835 amino acid analyzer after hydrolysis of the 
peptides in 6 N HC1 in vacuo at l l0°C for 24 h. 
Automatic amino acid sequencing was performed 
with an Applied Biosystems gas-phase sequencer 
[13]. 
3. RESULTS 
3.1. Preparation of the labelled enzyme 
Prior to labelling of the enzyme with dansyl- 
penicillin, the roles of dansyl-penicillin as a sub- 
strate and an inhibitor for the C. freundii cephalo- 
sporinase were investigated. The kcat value was 
5.2× 10 -2 s - l ,  and the Ki value for a competitive 
inhibitor was determined to be 3.2/~M. Dansyl- 
penicillin was also found to act as a progressive but 
reversible inhibitor of the enzyme. The enzyme ac- 
tivity was completely lost when the molar ratio of 
the probe to the enzyme was 20. However, the in- 
activated enzyme gradually regained its activity 
after removal of the free probe from the reaction 
medium, the rate of the restoration being approx. 
1.2× 10 -4 s - l .  
In order to label the cephalosporinase with the 
fluorescent probe, the enzyme (5.4 mg, 120 nmol) 
was incubated with 12/~mol dansyl-penicillin i  
0.37 ml of 50 mM sodium phosphate buffer (pH 
7.0) at 30°C for 5 min. The reaction was stopped 
by adding 1 vol. of acetic acid. Gel filtration was 
then carried out on a Sephadex G-25 column (100 
cm × 1.5 cm in diameter) in 1507o acetic acid at 5°C 
to remove free dansyl-peniciUin and the degrada- 
tion product. The protein fractions were pooled 
and lyophilized. 
To determine the extent of labelling, a part of 
the labelled enzyme was treated with 10°70 triethyl- 
amine at 37°C for 2 b and then fluorescence ( x- 
citation, 350 nm; emission, 550 nm) due to the 
liberated dansyl-penicilloic acid was measured. 
The molar ratio of the bound dansyl-penicillin to 
the enzyme was estimated to be 0.64. 
3.2. Isolation of the labelled peptide 
The labelled and lyophilized enzyme was dis- 
solved in 2 ml of 30 mM ammonium bicarbonate 
buffer (pH 7.9) containing 2 M urea. Trypsin (50 
/A; 1 mg/ml in 0.001 N HC1) was added and then 
the reaction mixture was incubated for 60 rain at 
37°C. Then a second portion of 50/A of the trypsin 
solution was added and the incubation continued 
for a further 60 min. The tryptic digest was directly 
fractionated by HPLC, and one major peak (T1; 
eluted at 19 min) and one minor peak (T2; eluted 
at 10 rain) were detected on the basis of the 
fluorescence (fig. 1). 
The T1 fractions (eluted between 18 and 20 min) 
were pooled and lyophilized (T1 peptides). One 
half of the T1 peptides was dissolved in 20°70 for- 
mic acid and then fractionated by a second HPLC 
under the conditions given above (fig.2A). From 
the three major peaks detected on the basis of ab- 
sorbance at 210 nm, the first peak (eluted at 19 
min) corresponded to the fluorescent peptide. 
However, the three peaks were too close for the 
respective components to be separated from each 
other. 
The dansyl-penicilloyl moiety was removed from 
the T1 peptides by 10% triethylamine treatment. It
was expected that the removal of the hydrophobic 
dansyl-penicilloyl moiety from the labelled peptide 
would result in shortening of the retention time on 
HPLC. As expected, a new peak appeared at 16 
min with a concomitant decrease in the labelled 
peptide peak (the first of the three major peaks) 
(fig.2B). Thus, the peptide that eluted at 16 min 
was identified as the active site fragment. 
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Fig.l. Fractionation of tryptic peptides by HPLC. The 
tryptic digest of the labelled enzyme (500/d) was applied 
to a reverse-phase wide-pore butyl (C4) column, and 
eluted as described in section 2. (A) UV detection with 
an ISCO V + UV detector at 210 nm. (B) Fluorescence 
detection with a Hitachi MPF4 fluorescence 
spectrophotometer (excitation 350 nm; emission, 550 
nm) after dilution of each fraction with 2 ml of 
acetonitrile. 
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Fig.2. HPLC of TI peptides. T1 peptides (A) or 
triethylamine-treated TI peptides (B) were subjected to 
a second HPLC, as described in the text, under the same 
conditions as in fig.1. 
Polyacrylamide gel electrophoresis of  the active 
site fragment labelled with TSP ITC gave a single 
band. The molecular mass was determined to be 
about 2600 Da, which corresponded to a peptide 
composed o f  22 amino acids. The amino acid com- 
posit ion of  this peptide was analyzed and the 
results are shown in table 1. 
The amino acid sequence of  the active site frag- 
ment was determined, with an automatic se- 
quencer, to be as shown in fig.3. The amino acid 
composi t ion calculated from the sequence was in 
good agreement with the results obtained with the 
amino acid analyzer except for a small difference 
(table 1). 
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Table 1 
Amino acid composition of the active site peptides 
of Citrobacter f eundii cephalosporinase 
Amino Number of residues per molecule 
acid Trypsin-thermo- 
lysin fragment 
Trypsin fragment 
From amino From 
acid analysis equencer From amino 
acid analysis 
Asp 2.4 3 - 
Thr 1.5 2 - 
Ser 2.4 2 1.4 
Glu 3.0 3 0.5 
Pro 0.9 1 - 
Gly 1.8 1 0.9 
Ala 1.9 2 - 
Val 2.1 2 0.4 
Ile 1.4 1 - 
Leu 2.0 2 1.0 
Phe 1.3 1 - 
Lys 1.0 1 0.6 
His 0.7 1 - 
3.3. Determination of the labelled residue 
The T1 peptides (approx. 10 nmol) were digested 
with thermolysin (0.2 mg) in 2 M urea at 37°C for 
2 h. The digest was fractionated by HPLC. One 
major peak (TH; eluted at 16.8 min) was detected 
on the basis of the fluorescence (not shown). The 
dansyl-penicilloyl moiety was removed from the 
TH peptides by 10°70 triethylamine treatment. The 
HPLC pattern of the treated peptides was com- 
pared with that of the untreated TH peptides. In 
this experiment, HPLC was performed under the 
conditions described in section 2 except hat a Zor- 
bax C8 column (25 cm x 0.46 cm in diameter) was 
used. Several new peaks appeared after the tri- 
ethylamine treatment (not shown). The amino acid 
composition of the smallest component (thermo- 
lytic peptide) among those in these new peaks is 
shown in table 1. On the basis of the sequence of 
the tryptic peptide, the thermolytic peptide was 
confirmed to coincide with the Leu-Gly-Ser frag- 
ment (fig.3). The residue labelled with dansyl- 
penicillin was the serine between glycine and 
valine. 
4. DISCUSSION 
The sequences around the active sites of the class 
C ~-lactamases of Pseudomonas aeruginosa, 
Escherichia coli K12 (amp C) and Enterobacter 
cloacae P99 have been established [9,10]. The cor- 
responding sequence determined in our work is 
very similar to that of the amp C ~]-lactamase; 19 
out of 22 residues are identical. Similarly, 18 out of 
22 residues and 12 out of 14 residues are the same 
as in the sequences of the E. cloacae P99 and P. 
aeruginosa ~-lactamases, respectively. 
The entire sequence of the structural gene of the 
C. freundii OS60 ~-lactamase was recently deter- 
mined by Lindberg and Normark [1]. The active 
site sequence directly determined from the peptide 
by us is consistent with the sequence at positions 
46-67, determined from the DNA sequence. The 
labelled serine corresponding to Ser-64 was con- 
firmed to be the active site serine. 
Dansyl-penicillin had previously only been used 
as a probe for a penicillinase-type enzyme Il l].  
The present work revealed that dansyl-penicillin 
exhibits far smaller values for both kcat (5.2 × 10 -2  
s -l) and Ki (3.2/~M) toward the cephalosporinase 
than the values for kcat (2× l03 s -~) and Km (200 
/~M) toward Bacillus cereusfl-lactamase I [11]. i.e., 
1 I I I * I I 
1 I.. I L Y 1 1 
Ala-Asp-lle-Ala-Asn-Asn-His-Pro-Val-Thr-Gln-Gln-Thr-Leu-Phe-Glu_Leu_Gl _ Ser-Val-Ser-Lys 
I Tryptie peptide I 
I I 
Thermolytie 
peptide 
Fig.3. The active site sequence of the C. freundii ~-lactamase. The common sequences with the E. coli amp c and E. 
cloacae P99 ~-lactamases are boxed. An asterisk indicates the labelled residue. 
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it forms a far more stable complex with the former 
enzyme than with the latter. Dansyl-penicillin may 
be useful for the identification of the active sites of 
other cephalosporinase-type enzymes. 
Dansyl-penicillin can be converted into a mech- 
anism-based inactivator for cephalosporinases (un- 
published). Dansyl-peniciUin sulfone is assumed to 
be a better probe than dansyl-penicillin. Fisher et 
al. [14] suggested that a second binding site for a 
sulfone-type inactivator, i.e., other than the serine 
residue, may play an important role in the stable 
formation of the inhibitor-enzyme complex. 
Dansyl-penicillin may be useful for the investiga- 
tion of this additional residue. 
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